PubMed

Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.

Johnson JA, Pohar SL, Majumdar SR.

Diabetes Care. 2006 Nov;29(11):2403-8.PMID: 17065675 [PubMed - indexed for MEDLINE]Related articlesFree article

Health care costs and mortality for Canadian urban and rural patients with diabetes: population-based trends from 1993-2001.

Pohar SL, Majumdar SR, Johnson JA.

Clin Ther. 2007;29 Spec No:1316-24.PMID: 18046931 [PubMed - indexed for MEDLINE]Related articles

Health care costs and mortality for Canadian urban and rural patients with diabetes: population-based trends from 1993-2001.

Pohar SL, Majumdar SR, Johnson JA.

Clin Ther. 2007 Jun;29(6 Pt 1):1316-24.PMID: 18036393 [PubMed - indexed for MEDLINE]Related articles

Health care utilization and costs in Saskatchewan's registered Indian population with diabetes.

Pohar SL, Johnson JA.

BMC Health Serv Res. 2007 Aug 13;7:126.PMID: 17697326 [PubMed - indexed for MEDLINE]Related articlesFree article

[Evaluation of the burden of diabetes in Poland]

Kissimova-Skarbek K, Pach D, Płaczkiewicz E, Szurkowska M, Szybiński Z.

Pol Arch Med Wewn. 2001 Sep;106(3):867-73. Polish. PMID: 11928598 [PubMed - indexed for MEDLINE]Related articles

The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.

Davis WA, Knuiman MW, Hendrie D, Davis TM.

Intern Med J. 2006 Mar;36(3):155-61.PMID: 16503950 [PubMed - indexed for MEDLINE]Related articles

Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.

Guo JJ, Gibson JT, Gropper DM, Oswald SL, Barker KN.

Am J Manag Care. 1998 Oct;4(10):1433-46.PMID: 10338736 [PubMed - indexed for MEDLINE]Related articlesFree article

Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL.

J Manag Care Pharm. 2006 Sep;12(7):546-54.PMID: 16981800 [PubMed - indexed for MEDLINE]Related articlesFree article

Health care use of individuals with diabetes in an employer-based insurance population.

Laditka SB, Mastanduno MP, Laditka JN.

Arch Intern Med. 2001 May 28;161(10):1301-8.PMID: 11371258 [PubMed - indexed for MEDLINE]Related articlesFree article

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271. PMID: 18308683 [PubMed - indexed for MEDLINE]Related articlesFree article

Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients.

Bickston SJ, Waters HC, Dabbous O, Tang BI, Rahman M.

J Manag Care Pharm. 2008 May;14(4):352-62.PMID: 18500913 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost of obesity in Canada.

Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH.

CMAJ. 1999 Feb 23;160(4):483-8.PMID: 10081464 [PubMed - indexed for MEDLINE]Related articlesFree article

Disease-related and all-cause health care costs of elderly patients with gout.

Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J, Krishnan E.

J Manag Care Pharm. 2008 Mar;14(2):164-75.PMID: 18331118 [PubMed - indexed for MEDLINE]Related articlesFree article

[Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis]

Wolfenstetter SB.

Gesundheitswesen. 2006 Oct;68(10):600-12. German. PMID: 17099820 [PubMed - indexed for MEDLINE]Related articles

The economic burden of nephropathy in diabetic patients in Germany in 2002.

Happich M, Landgraf R, Piehlmeier W, Falkenstein P, Stamenitis S.

Diabetes Res Clin Pract. 2008 Apr;80(1):34-9. Epub 2008 Jan 9.PMID: 18187227 [PubMed - indexed for MEDLINE]Related articles

Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.

Ringborg A, Martinell M, Stålhammar J, Yin DD, Lindgren P.

Int J Clin Pract. 2008 May;62(5):708-16. Epub 2008 Mar 17.PMID: 18355236 [PubMed - indexed for MEDLINE]Related articles

Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.

Burgess ED, Carides GW, Gerth WC, Marentette MA, Chabot I; Canadian Hypertension Society.

Can J Cardiol. 2004 May 1;20(6):613-8.PMID: 15152291 [PubMed - indexed for MEDLINE]Related articlesFree article

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.

[No authors listed]

Diabetes Care. 1998 Feb;21(2):296-309.PMID: 9539999 [PubMed - indexed for MEDLINE]Related articlesFree article

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL.

Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1. Erratum in: Clin Ther. 2006 Nov;28(11):1968-9. PMID: 17157128 [PubMed - indexed for MEDLINE]Related articles

Services and cost of hospitalization for children and adolescents with insulin-dependent diabetes mellitus in New South Wales.

Sutton L, Plant AJ, Lyle DM.

Med J Aust. 1990 Feb 5;152(3):130-6.PMID: 2300012 [PubMed - indexed for MEDLINE]Related articles